She would not run a marathon, but her quality of life clearly improved
For the millions living with advanced Parkinson's disease, the slow erosion of movement and rest has long seemed irreversible — a narrowing of life with few exits. Now, two teams of French researchers have offered early but meaningful evidence that some of what the disease takes may be reclaimed: a spinal cord implant that restored a woman's ability to walk, and a continuous medication pump that gave patients back their sleep. These are small steps, not cures, but in the landscape of a progressive illness, small steps carry profound weight.
- Advanced Parkinson's strips patients of basic freedoms — the ability to stand without fainting, to sleep without tremors — confining millions to beds and wheelchairs worldwide.
- A spinal cord implant targeting the brain's blood-pressure regulator allowed one woman to walk over 250 meters after surgery, when previously she collapsed after just a few steps.
- A pump delivering steady dopamine throughout the night eliminated the spike-and-crash cycle of standard medication, significantly improving sleep quality in a clinical trial versus placebo.
- Both breakthroughs remain early-stage — one tested on a single patient, the other on fewer than 50 — and neither has been studied extensively in Parkinson's patients specifically.
- Researchers and clinicians are calling for larger, more targeted trials before these interventions can reach the patients who need them most.
Advanced Parkinson's disease dismantles life incrementally. In its later stages, patients cannot walk without collapsing, cannot sleep through the night, and find themselves confined to beds or wheelchairs. Two recent findings from French researchers suggest that some of these losses may not be permanent.
The first involves orthostatic hypotension — a sharp drop in blood pressure when a person stands up, caused by damage to the brain's circulatory regulator. A 48-year-old woman was so severely affected that she fainted after just a few steps. Neurosurgeon Jocelyne Bloch and researcher Gregoire Courtine tested a spinal cord implant that stimulates the regulator to push blood upward when the body rises. Three months after surgery, she could walk more than 250 meters with a walking frame. "She is not cured, she would not run a marathon, but this surgery has clearly improved her quality of life," Bloch said. The results were published in the New England Journal of Medicine, though they represent a single case and require broader study.
The second advance addresses sleep. More than three-quarters of the world's 10 million Parkinson's patients experience serious sleep disruption, often caused by dopamine deficiency or the uneven effects of standard medication. A device resembling an insulin pump delivers apomorphine — a dopamine substitute — continuously through the night, avoiding the spikes and crashes that trigger muscle spasms. A randomized study in Lancet Neurology found significantly improved sleep in patients using the pump compared to those on placebo. Co-author Emmanuel Flamand-Roze noted that wearing a small pump while lying down is far less burdensome than carrying one all day.
Neither treatment is ready for widespread use. The implant study involved one patient; the pump trial fewer than 50. Larger, Parkinson's-specific trials are still needed. But for patients and families watching the disease close in, these results offer something rare: a concrete reason to believe that some of what is lost might yet be returned.
Advanced Parkinson's disease is a thief of small freedoms. Patients lose the ability to walk more than a few steps without collapsing. They cannot sleep through the night. In its later stages, the disease confines millions of people worldwide to beds or wheelchairs, eroding the motor functions that most of us take for granted. But two separate advances from French researchers, published in recent weeks, suggest that some of these losses might be recoverable.
The first obstacle is a condition called orthostatic hypotension. When a person with advanced Parkinson's stands up, their blood pressure drops sharply. The regulator in the brain that normally ensures adequate blood flow to the head when we rise has been disrupted by the disease. The result is dizziness, fainting, immobility. A 48-year-old woman experienced this so severely that she would collapse after taking just a few steps. She was initially diagnosed with Parkinson's disease itself, though her condition turned out to be distinct.
Neurosurgeon Jocelyne Bloch and researcher Gregoire Courtine, working in France, tested a spinal cord implant on this woman. The device works differently depending on the problem it addresses. For paralyzed patients, it mimics the electrical pulses the brain normally sends to muscles, reconnecting a severed link. For orthostatic hypotension, it targets the brain's regulator directly, stimulating it to send more blood when the body stands upright. Three months after surgery, the woman could walk more than 250 meters with a walking frame—a distance she could not have covered before. "She is not cured, she would not run a marathon, but this surgery has clearly improved her quality of life," Bloch told the AFP news agency. The research was published in the New England Journal of Medicine, and it represents a significant proof of concept, though it remains a single case. Whether the same approach will work for Parkinson's patients specifically remains uncertain and requires further study.
The second problem is insomnia. More than three-quarters of the world's 10 million Parkinson's patients experience sleep disruption. Some are awakened by uncontrolled shaking. Others suffer from a lack of dopamine, the neurotransmitter that regulates movement and mood. The standard medication, apomorphine, replaces dopamine and reduces symptoms like tremors and stiffness. But when taken as a pill, it causes dopamine levels to spike and then crash, triggering muscle spasms that further disrupt sleep.
A device resembling an insulin pump offers a different approach. It delivers apomorphine continuously throughout the night, maintaining steady dopamine levels rather than creating peaks and valleys. A randomized study published in the journal Lancet Neurology found that patients using the pump experienced significantly improved sleep compared to those receiving a placebo. Emmanuel Flamand-Roze, who co-authored the research, noted that wearing a small pump at night is far less burdensome than carrying one throughout the day. The constraint is manageable when you are lying down.
Both treatments remain early-stage. The spinal implant study involved a single patient. The pump study included fewer than 50 people, all at an advanced stage of disease. Neither has been tested extensively on Parkinson's patients specifically. Researchers acknowledge that larger, more targeted trials are necessary before these interventions can move into widespread clinical use. But for patients and families facing the progressive narrowing of life that advanced Parkinson's brings, these results offer something that has been scarce: a concrete reason to believe that some of what the disease takes away might be given back.
Citas Notables
She is not cured, she would not run a marathon, but this surgery has clearly improved her quality of life— Neurosurgeon Jocelyne Bloch
The constraints linked to wearing a small pump are much lower during the night, compared to carrying such a device around all day— Researcher Emmanuel Flamand-Roze
La Conversación del Hearth Otra perspectiva de la historia
Why does Parkinson's cause people to faint when they stand up? That seems like a separate problem from the shaking and stiffness we usually hear about.
It is separate, and that's what makes it so insidious. The disease damages the brain's ability to regulate blood pressure. When you stand, your brain is supposed to sense that and tell your body to push more blood upward. In Parkinson's patients, that signal breaks down. So they stand and suddenly there's not enough blood reaching their head.
And the spinal implant somehow fixes that signal?
Not fixes—it bypasses the broken part. The implant stimulates the regulator directly, telling it to do what it should be doing on its own. It's like having someone manually flip a switch that your brain can no longer flip automatically.
But the study was just one patient. Why publish it if it's just one case?
Because it worked in a way that seemed impossible before. She went from fainting after a few steps to walking 250 meters. That's not a marginal improvement. It's proof the mechanism works. But you're right—one person doesn't tell you if it will work for thousands of Parkinson's patients with the same problem.
What about the pump for sleep? That seems more straightforward.
It is, in a way. The problem isn't new—doctors have known apomorphine helps Parkinson's symptoms. The problem is how it gets into the body. A pill creates a boom-and-bust cycle of dopamine. A pump smooths it out. But again, the study was small, and it only looked at people already very far along in the disease.
So both treatments are promising but unproven.
Exactly. They're proof of concept. They show the direction is right. But they're not ready for most patients yet.